1. New Technology: Bioptigen SDOCT Boosts Flexibility

    New Technology: Bioptigen SDOCT Boosts Flexibility

    Technology features a hand-held probe, presenting new opportunities for researchers and clinicians. With the introduction of spectral domain optical coherence tomography (SDOCT), clinicians and researchers now can noninvasively image ocular structures much more quickly and in unprecedented three-dimensional detail. One contender in the growing spectral domain market, the Bioptigen SDOCT, provides a novel feature—hand-held imaging—opening a new world of capabilities to researchers and clinicians, in addition to the advantages of rapid acquisition of high-quality depth-resolved images, superior resolution and real-time imaging. "We are focused on providing our system to specialists and lead adopters who really care about providing ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

    1. We are focused on providing our system to specialists and lead adopters who really care about providing the most in-depth analysis of images for diagnosis and treatment of ocular disease.
    2. We use it for research purposes principally...It's a state-of-the-art spectral domain that one could use for clinical purposes, but the hand-held capability is unique," he says. "We've used it in the operating room on adults. You can use it on children. We've used it on many animals, and that's where there's nothing that has its capabilities.
    3. Our user capabilities are primarily for research purposes, and we find it's superb for that.
    4. There's not a single patient who walks through the door that you couldn't image if you needed to.
    5. That's going to give you a reason to treat some of these patients, so I think higher quality imaging of very subtle changes and imaging more of the retina in a very short period of time is just going to give us more information about the patient.
    6. Bioptigen allows you to sum up multiple images of a particular cut.
    7. But for other diseases where maybe it's a more subtle disruption of say, the photoreceptor layer, it might be very valuable.
    8. We have protocol-driven software, so the practice can set up a series of images that they want to do repeatedly and, with one click, load a series of image scan settings that they want to take and have their photographer run through them very quickly.
  3. Topics Mentioned